Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-12-08
2010-12-14
Blanchard, David J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S133100, C424S141100, C424S145100, C435S069600, C435S070210, C530S387300, C530S388100, C530S388220
Reexamination Certificate
active
07851601
ABSTRACT:
Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.
REFERENCES:
William E. Paul. Fundamental Immunology, 3rd ed., p. 242, 1993.
Holliger et al. Proc. Natl. Acad. Sci. USA, 90(14):6444-6443, 1993.
Supplementary European Search Report dated Mar. 23, 2010 in European Application No. 07744826.4.
Khong et al., “Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis,” Kidney International, vol. 58, No. 3, pp. 1098-1107 (2000).
Kipriyanov et al., “Generation and Production of Engineered Antibodies,” Molecular Biotechnology, vol. 26, No. 1, pp. 39-60 (2004).
Miyamoto et al., “Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy,” Cancer Science, vol. 97, No. 5, pp. 341-347 (2006).
Miyamoto et al., “Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy,” Cancer Research, vol. 64, No. 16, pp. 5720-5727 (2004).
Adams et al., “Monoclonal antibody therapy of cancer,” Nature Biotechnology, vol. 23, No. 9, pp. 1147-1157 (2005).
Ando Hiroshi
Furuya Akiko
Iwamoto Ryo
Masuda Kazuhiro
Mekada Eisuke
Blanchard David J.
Kyowa Hakko Kirin Co., Ltd.
Sughrue & Mion, PLLC
LandOfFree
Monoclonal antibody capable of binding to heparin-binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody capable of binding to heparin-binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody capable of binding to heparin-binding... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4174611